| Financial Year |
September 30 2022 |
| Monetary Funds |
243,805,976.38 |
| Held-for-trading Financial Assets |
13,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
290,891,492.00 |
| Advances to Suppliers |
23,698,919.98 |
| Other Receivables |
102,079,791.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
301,674,569.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,128,622.93 |
| Total Current Assets |
983,642,005.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
56,925,177.46 |
| Investment Properties |
810,338,700.00 |
| Fixed Assetes |
396,265,233.04 |
| Under-construction Projects |
18,100,765.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
64,252,928.20 |
| R&D expenses |
-- |
| Goodwill |
61,193,369.40 |
| Long-Term Deferred and Prepaid Expenses |
26,919,081.64 |
| Deferred Income Tax Assets |
32,312,037.04 |
| Other Non-Current Assets |
31,520,571.50 |
| Sub-Total of Non-Current Assets |
1,633,355,635.64 |
| Total Assets |
2,616,997,641.39 |
| Short-Term Loans |
333,098,609.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
160,916,450.00 |
| Accounts Payable |
210,065,825.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,221,498.03 |
| Taxes Payable |
13,021,681.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
100,795,371.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
31,482,034.83 |
| Other Current Liabilities |
4,871,376.11 |
| Sub-Total of Current Liabilities |
906,944,970.64 |
| Long-term Loans |
287,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
148,012,929.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
497,883,561.88 |
| Total Liabilities |
1,404,828,532.52 |
| Paid-In Capital(Or Share Stock) |
926,500,000.00 |
| Capital Surplus |
195,436,092.77 |
| Surplus Reserve |
72,853,943.26 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-130,789,596.44 |
| Minority Stockholder's Interest |
13,087,843.50 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,199,081,265.37 |
| Owner's Equity（Stockholder's Equity） |
1,212,169,108.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,616,997,641.39 |
